GLP-1 Medications May Increase Hair Loss Risk in Some Men

Topic: Health

A new study found that men taking GLP-1 medications for diabetes and obesity may face a higher risk of hair loss. Researchers discovered a link between the genetic activity related to GLP-1 use and male-pattern hair loss.

Men who take drugs like Ozempic, Wegovy, and Zepbound for type 2 diabetes and obesity may be at a higher risk of losing their hair. This is especially true for men who are already genetically predisposed to the most common type of hair loss.

A study by researchers at NYU Langone Health found that these medications can increase the risk of hair loss by 7%. The team examined the GLP1R gene, which influences levels of glucagon-like peptide-1 (GLP-1) receptor proteins in the body. They compared genetic patterns associated with GLP1R activity to those found in men who have androgenetic alopecia, a type of hair loss that typically affects the top and front of the scalp.

The researchers also looked at other conditions that might explain the link between GLP-1 use and hair loss, such as hypertension and reduced testosterone levels. However, they found that these factors did not account for the increased risk.

Why It Matters

This study is important because it could help doctors identify people who may be more likely to experience hair loss when taking GLP-1 medications. This could lead to better treatment options and a more personalized approach to prescribing these medications.

Key Facts

• A new study found that men taking GLP-1 medications for diabetes and obesity may face a higher risk of hair loss, especially if they are already genetically predisposed to the most common type of hair loss.
• The researchers discovered a link between genetic activity related to GLP-1 use and male-pattern hair loss, which increased the risk by 7%.
• The study was conducted by researchers at NYU Langone Health and published in the Journal of Investigative Dermatology.
• GLP-1 medications include Ozempic, Wegovy, and Zepbound, which are used to treat type 2 diabetes and obesity.
• Androgenetic alopecia is a type of hair loss that typically affects the top and front of the scalp.

Key Terms

GLP-1

A hormone that helps regulate blood sugar levels

GLP1R gene

A gene that influences levels of GLP-1 receptor proteins in the body

Androgenetic alopecia

A type of hair loss that is caused by hormones and genetics

Implications

This study is important because it could help doctors identify people who may be more likely to experience hair loss when taking GLP-1 medications. This could lead to better treatment options and a more personalized approach to prescribing these medications.